A
Anne Gompel
Researcher at Paris Descartes University
Publications - 282
Citations - 8839
Anne Gompel is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Breast cancer & Menopause. The author has an hindex of 51, co-authored 271 publications receiving 7878 citations. Previous affiliations of Anne Gompel include University of Paris & Frederiksberg Hospital.
Papers
More filters
Journal ArticleDOI
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Cynthia A. Stuenkel,Cynthia A. Stuenkel,Susan R. Davis,Anne Gompel,Mary Ann Lumsden,Mary Ann Lumsden,M. Hassan Murad,JoAnn V. Pinkerton,JoAnn V. Pinkerton,Richard J. Santen,Richard J. Santen +10 more
TL;DR: Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and other symptoms of the climacteric and benefits may exceed risks for the majority of symptomatic postmenopausal women who are under age 60 or under 10 years since the onset of menopause.
Journal ArticleDOI
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
Elisabeth Luporsi,Fabrice Andre,Frédérique Spyratos,Pierre-Marie Martin,Jocelyne Jacquemier,Frédérique Penault-Llorca,Nicole Tubiana-Mathieu,Brigitte Sigal-Zafrani,Laurent Arnould,Anne Gompel,Caroline Egele,Bruno Poulet,Krishna B. Clough,Hubert Crouet,Alain Fourquet,Jean-Pierre Lefranc,Carole Mathelin,Nicolas Rouyer,Daniel Serin,Marc Spielmann,Margaret Haugh,Marie-Pierre Chenard,Etienne Brain,Patricia de Cremoux,Jean-Pierre Bellocq +24 more
TL;DR: KI-67 is an independent prognostic factor for disease-free survival in multivariate analyses studies using samples from randomized clinical trials with secondary central analysis of the biomarker, and its prognostic and predictive value is focused on.
Journal ArticleDOI
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
T. J. de Villiers,Amos Pines,Nicholas Panay,Marco Gambacciani,David F. Archer,Rodney Baber,Susan R. Davis,Anne Gompel,Victor W. Henderson,Robert Langer,Roger A. Lobo,Geneviève Plu-Bureau,David W. Sturdee +12 more
TL;DR: This study aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about prolapse preoperatively and the importance of cleanliness and tubal integrity in the early stages of pregnancy.
Journal ArticleDOI
Evaluation of Gonadal Function in 107 Intersex Patients by Means of Serum Antimüllerian Hormone Measurement
Rodolfo Rey,Corinne Belville,Claire Nihoul-Fékété,Laurence Michel-Calemard,Maguelone G. Forest,Najiba Lahlou,Francis Jaubert,Irène Mowszowicz,Michel David,Nurçin Saka,Claire Bouvattier,Anne-Marie Bertrand,Claudine Lecointre,Sylvie Soskin,Sylvie Cabrol,Hélène Crosnier,Juliane Léger,Stephen Lortat-Jacob,Marc Nicolino,Wolfgang Rabl,Sergio P. A. Toledo,Firdevs Bas,Anne Gompel,Paul Czernichow,Pierre Chatelain,Raphaël Rappaport,Yves Morel,Nathalie Josso +27 more
TL;DR: Serum AMH determination is a powerful tool to assess Sertoli cell function in children with intersex states, and it helps to distinguish between defects of male sexual differentiation caused by abnormal testicular determination and those resulting from isolated impairment of testosterone secretion or action.
Journal ArticleDOI
Prevention of diseases after menopause
Roger A. Lobo,Susan R. Davis,T. J. de Villiers,Anne Gompel,Victor W. Henderson,Howard N. Hodis,Mary Ann Lumsden,Wendy J. Mack,Samuel Shapiro,Rodney Baber +9 more
TL;DR: As part of a comprehensive strategy to prevent chronic disease after menopause, menopausal hormone therapy, particularly estrogen therapy, may be considered as part of the armamentarium.